Board Meeting

VIMTA LABS LTD.

NSE : VIMTALABSBSE : 524394ISIN CODE : INE579C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE460.551.45 (+0.32 %)
PREV CLOSE ( ) 459.10
OPEN PRICE ( ) 463.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 906
TODAY'S LOW / HIGH ( )455.85 470.00
52 WK LOW / HIGH ( )346.65 621.4
NSE460.200.8 (+0.17 %)
PREV CLOSE( ) 459.40
OPEN PRICE ( ) 457.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 460.20 (310)
VOLUME 15313
TODAY'S LOW / HIGH( ) 456.10 470.40
52 WK LOW / HIGH ( )347.3 623.15

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.